E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/29/2005 in the Prospect News Biotech Daily.

Medtronic's Vertex Reconstruction System approved for cranial stabilization

By E. Janene Geiss

Philadelphia, Nov. 29 - Medtronic, Inc. announced Tuesday that its previously released Vertex Reconstruction System is now indicated for use in cranial stabilization.

Vertex consists of occipitocervical plate/rods, screws, hooks and other connecting components intended to provide stabilization to promote fusion of the occipitocervical spine, cervical spine and the upper thoracic spine, according to a company news release.

The system is indicated for use in cases of degenerative disc disease, spinal stenosis (narrowing of the spinal canal), spondylolithesis (forward shifting of vertebra position), fracture, dislocation, tumors and failed previous fusions, officials said.

In the surgical procedure, a surgeon enters through the back of a patient's neck and uses titanium rods, multi-axial screws and hooks of the Vertex system to stabilize a patient's head with the neck. The stabilization helps encourage fusion, officials said.

The system originally received 510(k) clearance from the U.S. Food and Drug Administration for laminar hook placement on the C1 - T3 vertebrae and for pedicle screw use on the T1 - T3 vertebrae. The occipitocervical clearance was granted in September 2005.

Medtronic Sofamor Danek is a Memphis, Tenn., developer of spine therapeutics to treat spinal disorders.

Medtronic, Inc. is based in Minneapolis and focuses on development of medical technology to alleviate pain, restore health and extending life for people around the world.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.